Prognostic value of des-γ-carboxy prothrombin in patients with hepatocellular carcinoma treated with transarterial chemotherapy: A systematic review and meta-analysis-Reference-Cited by-同舟云学术

Prognostic value of des-γ-carboxy prothrombin in patients with hepatocellular carcinoma treated with transarterial chemotherapy: A systematic review and meta-analysis

Published:2019-11-15 Issue:11 Volume:14 Page:e0225170
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Yang Ming^ORCID,Zhang Xuejun,Liu Jinlong

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference29 articles.

1. Toshifumi Tada1,Yuji Kaneoka,Atsuyuki Maeda. A Novel method to measure serum levels of des-gamma-carboxy prothrombin for hepatocellular carcinoma in patients taking warfarin: a preliminary report;Hidenori Toyoda;Cancer science,2012

2. Des-gamma-carboxy (abnormal) prothrombin as a serum marker of primary hepatocellular carcinoma;HA Liebman;The New England Journal of Medicine,1984

3. Des-gamma-carboxy prothrombin and alpha-fetoprotein as biomarkers for the early detection of hepatocellular carcinoma;HR Kim;Gastroenterology,2010

4. Effectiveness of PIVKA-II in the detection of hepatocellular carcinoma based on real-world clinical data;Rentao Yu;BMC Cancer,2017

5. Comparison of transcatheter arterial chemoembolization and transcatheter arterial chemotherapy infusion for patients with intermediate-stage hepatocellular carcinoma;H Nishikawa;Oncology reports,2014

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Merits and boundaries of the BCLC staging and treatment algorithm: Learning from the past to improve the future with a novel proposal;Journal of Hepatology;2024-04

2. Biomarker discovery and validation for gastrointestinal tumors: A comprehensive review of colorectal, gastric, and liver cancers;Pathology - Research and Practice;2024-03

3. Existing and emerging biomarkers in hepatocellular carcinoma: relevance in staging, determination of minimal residual disease, and monitoring treatment response: a narrative review;Hepatobiliary Surgery and Nutrition;2024-02

4. Role of protein induced by vitamin-K absence-II in transplanted patients with HCC not producing alpha-fetoprotein;Liver Transplantation;2023-09-19

5. Personalised management of patients with hepatocellular carcinoma: a multiparametric therapeutic hierarchy concept;The Lancet Oncology;2023-07